PEMBROLIZUMAB
UNII DPT0O3T46P

Substance Identification & Data

This profile provides standardized clinical and technical data for Pembrolizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) DPT0O3T46P.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1374853-91-4 and the RxNorm Concept ID (RxCUI) 1547545. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

DPT0O3T46P

CAS Registry Number

1374853-91-4

RxNorm Concept ID

1547545

Detailed Substance Profile

Preferred Name

PEMBROLIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

DPT0O3T46P

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C106432

National Cancer Institute reference terminology for clinical and research data.

INN ID

9798

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

ZZ-165

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Pembrolizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PEMBROLIZUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G4, ANTI-(HUMAN PROTEIN PDCD1 (PROGRAMMED CELL DEATH 1)) (HUMAN-MUS MUSCULUS MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL LIGHT CHAIN, DIMER

LAMBROLIZUMAB

MK 7684A COMPONENT PEMBROLIZUMAB

MK-1308A COMPONENT PEMBROLIZUMAB

PEMBROLIZUMAB [INN]

PEMBROLIZUMAB [JAN]

PEMBROLIZUMAB [MI]

PEMBROLIZUMAB [PURPLE BOOK CDER]

PEMBROLIZUMAB [USAN]

PEMBROLIZUMAB [VANDF]

PEMBROLIZUMAB [WHO-DD]